Tel.: 514-340-8248
email address
Dr. Richard Margolese
 
Senior Investigator, Lady Davis Institute
Herbert Black Chair in Surgical Oncology, McGill University
Professor, Departments of Surgery and Oncology, McGill University

Dr. Margolese's Publications Indexed on PubMed
 
Following undergraduate studies at Dartmouth College, Dr. Richard Margolese earned his M.D. from McGill University. He completed his residency at Mount Sinai Hospital in New York and a fellowship at the Roswell Park Institute in Buffalo before joining the staff at the Jewish General Hospital (JGH). From 1997 to 2006, he served as Chief the Department of Oncology. He was among the first to recognize that more conservative surgeries could be as effect in treating breast cancer as radical mastectomies, and is an internationally recognized authority on breast conserving surgery for women with breast cancer.

Among the many honours conferred over his career, Dr. Margolese was named to the Order of Canada in 1997, received the R.M. Taylor Medal and Award from the Canadian Cancer Society in 2000, and the Distinguished Lifetime Achievement Award of the National Surgical Breast and Bowel Project in 2006.

Dr. Margolese has participated in clinical research studies in breast cancer. He and his colleagues showed that radical breast surgery could be replaced by breast conserving surgery, and that adding chemotherapy and hormone therapies such as tamoxifen could improve long-term outcomes by diminishing the rate of recurrence. In one trial, comparing tamoxifen after surgery to surgery alone, they showed that not only was the cure rate improved but that new cancers in the opposite breast were diminished. This led to the idea of prevention and, indeed, two prevention trials successfully showed that approximately half of the cancers could be prevented in selective women with high risk profiles. These trials continue and Dr. Margolese continues his involvement in modern clinical trials.


Major Research Activities

Clinical trials of promising new anti-cancer therapies. Clinical trials in: breast cancer surgery, adjuvant therapy in breast cancer, and breast cancer prevention.

Recent Publications
 
Rastogi P, Anderson SJ, Bear HD, Geyer CE, Kahlenberg MS, Robidoux A, Margolese RG, Hoehn JL, Vogel VG, Dakhil SR, Tamkus D, King KM, Pajon ER, Wright MJ, Robert J, Paik S, Mamounas EP, Wolmark N. "Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27." J Clin Oncol. 2008 Feb 10;26(5):778-85.

Sigal JJ, Claude Ouimet M, Margolese R, Panarello L, Stibernik V, Bescec S. "How patients with less-advanced and more-advanced cancer deal with three death-related fears: an exploratory study." J Psychosoc Oncol. 2008; 26(1):53-68.
Snapshot

Dr. Richard Margolese is internationally recognized for his pioneering work in breast conserving surgery for women with breast cancer.

His clinical specialties include medical oncology, surgical oncology, and breast cancer.

 
 
Important Links


Support research at the Lady Davis Institute - Jewish General Hospital